These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17540335)

  • 1. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy.
    Christin-Maître S; Delemer B; Touraine P; Young J
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):106-12. PubMed ID: 17540335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a macroprolactinoma in association with hormone replacement therapy in a perimenopausal woman with presumed idiopathic hyperprolactinemia.
    Orrego JJ; Bair J
    Endocr Pract; 2006; 12(2):174-8. PubMed ID: 16690466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormones and breast cancer.
    Wile AG; DiSaia PJ
    Am J Surg; 1989 Apr; 157(4):438-42. PubMed ID: 2648885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis.
    Colao A; Vitale G; Cappabianca P; Briganti F; Ciccarelli A; De Rosa M; Zarrilli S; Lombardi G
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1704-11. PubMed ID: 15070934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary medical therapy of micro- and macroprolactinomas in men.
    Pinzone JJ; Katznelson L; Danila DC; Pauler DK; Miller CS; Klibanski A
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3053-7. PubMed ID: 10999785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactinoma and pregnancy: From the wish of conception to lactation.
    Maiter D
    Ann Endocrinol (Paris); 2016 Jun; 77(2):128-34. PubMed ID: 27130071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia.
    Corenblum B; Donovan L
    Fertil Steril; 1993 Mar; 59(3):671-3. PubMed ID: 8458475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy.
    Garcia MM; Kapcala LP
    J Endocrinol Invest; 1995 Jun; 18(6):450-5. PubMed ID: 7594240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients.
    Domingue ME; Devuyst F; Alexopoulou O; Corvilain B; Maiter D
    Clin Endocrinol (Oxf); 2014 May; 80(5):642-8. PubMed ID: 24256562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment issues in female hyperprolactinaemia.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term management of prolactinomas.
    Schlechte JA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2861-5. PubMed ID: 17682084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.